Care management in amyotrophic lateral sclerosis
- PMID: 28461024
- DOI: 10.1016/j.neurol.2017.03.031
Care management in amyotrophic lateral sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal neurodegenerative disease characterized by progressive weakness of voluntary muscles of movement as well as those for swallowing, speech and respiration. In the absence of curative treatment, care can improve quality of life, prolong survival, and support ALS patients and their families, and also help them to anticipate and prepare for the end of life. Multidisciplinary management in tertiary centers is recommended in close collaboration with general practitioners, home carers and a dedicated health network. Patients' follow-up deals mainly with motor impairment and physical disability, adaptation, nutrition and respiratory function. Involvement of palliative care as part of the multidisciplinary team management offers patients the possibility of discussing their end of life issues. This review summarizes the different aspects of ALS care, from delivering the diagnosis to the end of life, and the organization of its management.
Keywords: ALS management; Amyotrophic lateral sclerosis; Ethics; Non-invasive ventilation; Nutrition; Palliative care; Rehabilitation.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever.Arq Neuropsiquiatr. 2009 Sep;67(3A):750-82. doi: 10.1590/s0004-282x2009000400040. Arq Neuropsiquiatr. 2009. PMID: 19722069 Review.
-
Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best".JAMA. 2007 Jul 11;298(2):207-16. doi: 10.1001/jama.298.2.207. JAMA. 2007. PMID: 17622602
-
Amyotrophic lateral sclerosis: a team approach to primary care.Clin Excell Nurse Pract. 1999 Nov;3(6):337-45. Clin Excell Nurse Pract. 1999. PMID: 10865571 Review.
-
Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review.Rev Neurol (Paris). 2017 May;173(5):300-307. doi: 10.1016/j.neurol.2017.03.032. Epub 2017 May 4. Rev Neurol (Paris). 2017. PMID: 28479121 Review.
-
Palliative care principles in ALS.Handb Clin Neurol. 2023;191:139-155. doi: 10.1016/B978-0-12-824535-4.00007-0. Handb Clin Neurol. 2023. PMID: 36599506 Review.
Cited by
-
Nissl Granules, Axonal Regeneration, and Regenerative Therapeutics: A Comprehensive Review.Cureus. 2023 Oct 28;15(10):e47872. doi: 10.7759/cureus.47872. eCollection 2023 Oct. Cureus. 2023. PMID: 38022048 Free PMC article. Review.
-
Evidence-based position paper on Physical and Rehabilitation Medicine practice for people with amyotrophic lateral sclerosis.Eur J Phys Rehabil Med. 2022 Apr;58(2):271-279. doi: 10.23736/S1973-9087.21.07120-3. Epub 2021 Nov 17. Eur J Phys Rehabil Med. 2022. PMID: 34786907 Free PMC article.
-
Reliability and Validity of the Korean version of the Center for Neurologic Study Bulbar Function Scale (K-CNS-BFS): An observational study.Medicine (Baltimore). 2024 Jun 21;103(25):e38216. doi: 10.1097/MD.0000000000038216. Medicine (Baltimore). 2024. PMID: 38905379 Free PMC article.
-
Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network.PLoS One. 2021 Jan 6;16(1):e0244604. doi: 10.1371/journal.pone.0244604. eCollection 2021. PLoS One. 2021. PMID: 33406098 Free PMC article.
-
Enhanced Acute Muscle Activation in ALS Patients Following Liposomal Curcumin, Resveratrol, and Dutasteride Administration.Pharmaceuticals (Basel). 2025 Mar 28;18(4):497. doi: 10.3390/ph18040497. Pharmaceuticals (Basel). 2025. PMID: 40283933 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous